Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better
DNAGinkgo Bioworks (DNA) Seeking Alpha·2024-11-18 23:36

Ginkgo Bioworks (NYSE: DNA ) reported solid results in the third quarter, although the company's performance was weaker than the financials suggest, as Ginkgo recognized 45 million USD of non-cash revenue that has no value. Ginkgo's transition away from downstream valueRichard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the result of a poor understanding of a businesses long-term prospects. Narweena believes that excess risk adjusted returns can be achi ...